tylophorine has been researched along with Carcinoma, Anaplastic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chao, YS; Chuang, TH; Lee, SJ; Lee, YZ; Wu, CM; Wu, PL; Yang, CW | 1 |
Chang, HY; Chao, YS; Hsu, HY; Lee, SJ; Lee, YZ; Wu, CM; Yang, CW | 1 |
2 other study(ies) available for tylophorine and Carcinoma, Anaplastic
Article | Year |
---|---|
Tylophorine arrests carcinoma cells at G1 phase by downregulating cyclin A2 expression.
Topics: Alkaloids; Antineoplastic Agents; Carcinoma; Cell Line, Tumor; Cyclin A; Cyclin A2; Down-Regulation; G1 Phase; Gene Expression Regulation, Neoplastic; Humans; Indolizines; Phenanthrenes; Transcription, Genetic | 2009 |
c-Jun-mediated anticancer mechanisms of tylophorine.
Topics: Activating Transcription Factor 1; Alkaloids; Antineoplastic Agents, Phytogenic; Carcinoma; Cell Line, Tumor; Cyclin A2; Down-Regulation; Elongation Factor 2 Kinase; Eukaryotic Initiation Factors; G1 Phase Cell Cycle Checkpoints; Hep G2 Cells; Humans; Indolizines; JNK Mitogen-Activated Protein Kinases; MAP Kinase Signaling System; NF-kappa B; Phenanthrenes; Phenanthrolines; Phosphatidylinositol 3-Kinases; Phosphorylation; Promoter Regions, Genetic; Protein Kinase C-delta; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins c-jun; Pyruvate Dehydrogenase Acetyl-Transferring Kinase; RNA Interference; RNA, Small Interfering; Transcription Factor AP-1; Tylophora | 2013 |